tirzepatide for seniors Zepbound: GLP-1s May Raise Frailty, Muscle Loss Risk in Older Adults Tirzepatide for Obesity and Diabetes

According to NICE guideline NG28 , GLP-1 receptor agonists like Ozempic may be considered for adults with type 2 diabetes who have specific criteria, including a BMI of 35 kg/m or higher (adjusted for ethnicity) and specific problems associated with high weight, or a BMI lower than 35 kg/m where insulin would have significant occupational implications or weight loss would benefit other significant obesity-related comorbidities

The growth hormone receptor upregulation BPC-157 promotes may also contribute to cardiac benefits

Fancy COAs that look legit until you realize they tell you almost nothing

A modest decline is expected during calorie restriction